In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
When the relevant market is your work force: How labor law may inform M&A
Antitrust laws prohibit firms from restricting competition in both product and labor markets. However, government officials have focused most of their...